Watson Pharmaceuticals jas announced that R. Todd Joyce has been named Senior Vice President and Chief Financial Officer (CFO) effective immediately. Mr. Joyce succeeds Mark W. Durand, who has departed as CFO for personal reasons. On July 27, 2009, Watson announced that Mr. Durand had taken a leave of absence for health reasons, and named Mr. Joyce as Acting Principal Financial Officer.
Mr. Joyce joined Watson in [private] 1997 as Corporate Controller, and was named Vice President, Corporate Controller and Treasurer in 2001. During the period of October 2006 to November 2007, Mr. Joyce served as Interim Principal Financial Officer. He joined Watson from ICN Pharmaceuticals where he served as Vice President of Tax from 1992-1996, and Vice President of Tax and Finance from 1996 until 1997. Prior to ICN, Mr. Joyce served as a Certified Public Accountant for Coopers & Lybrand and Price Waterhouse.
Mr. Joyce has a BS in Business Administration from University of North Carolina at Chapel Hill, and a MS in Taxation from Golden Gate University.[/private]
Watson Pharmaceuticals, Inc., (NYSE: WPI) is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).
Related tax articles that may interest you:
- Towers Perrins and Watson Wyatt Merge ! Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide,...
- Director of Reward and Employment Tax Appointed at Armstrong Watson Accountancy firm Armstrong Watson has announced the promotion of Nick...
- Former Watson Wyatt Head of Tax joins Creaseys Award winning Chartered Accountants Creaseys LLP has recruited a new...
- Armstrong Watson and Manson & Partners merge Armstrong Watson, the top 30-ranked UK accountancy firm, is significantly...
- Viacom Names James W. Barge Executive Vice President, Controller, Tax and Treasury Viacom Inc. has announced that it has appointed James W....
